Respiratory microbiome composition in children offers new ideas for precision treatment of respiratory diseases and asthma
This narrative review focuses on the respiratory microbiome, including its composition, metabolites, and colonization status within pediatric populations. The scope covers children affected by respiratory infections, allergic airway inflammation, asthma, and other respiratory diseases. The authors discuss how these factors relate to the broader context of respiratory health in this age group.
The authors provide new ideas and directions for research on pathogenesis and clinical precision treatment based on the available information. No specific quantitative results, p-values, or confidence intervals were reported in this source. Safety data, including adverse events and tolerability, were not reported in this source.
The review does not establish causal links between microbiome changes and clinical outcomes. The findings are intended to guide future research rather than inform immediate clinical practice. Limitations regarding the lack of specific data are acknowledged through the absence of reported numerical outcomes.